Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRO MEDICUS LIMITED Director's Dealing 2013

Sep 10, 2013

65579_rns_2013-09-10_ced23845-747f-4bfd-9a06-f32bb6097b54.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Terence KEMPEN
Date of last notice 20 September 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Part 1 - Change of director’s relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trustNote: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should bedisclosed in this part.Direct or indirect interestIndirectNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Ordinary fully paid shares in Pro MedicLimitedheldbytheElaineKempSuperannuation Fund of which the Directoa Trustee and Member Part 1 - Change of director’s relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trustNote: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should bedisclosed in this part.Direct or indirect interestIndirectNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Ordinary fully paid shares in Pro MedicLimitedheldbytheElaineKempSuperannuation Fund of which the Directoa Trustee and Member Part 1 - Change of director’s relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trustNote: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should bedisclosed in this part.Direct or indirect interestIndirectNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Ordinary fully paid shares in Pro MedicLimitedheldbytheElaineKempSuperannuation Fund of which the Directoa Trustee and Member Part 1 - Change of director’s relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trustNote: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should bedisclosed in this part.Direct or indirect interestIndirectNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Ordinary fully paid shares in Pro MedicLimitedheldbytheElaineKempSuperannuation Fund of which the Directoa Trustee and Member
Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Ordinary fully paid shares in Pro MedicLimitedheldbytheElaineKempSuperannuation Fund of which the Directoa Trustee and Member usenr is
Date of change 10 September 2013
No. of securities held prior to change 378082 ordinary shares
,200000 ordinar share otions
Class Ordinary shares
Number acquired 50,000
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.43 cents per share
No. of securities held after change 428,082 ordinary shares200,000 ordinary share options
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Nature of change On market purchase Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Detail of contract N/A N/A N/A N/A N/A
Natu re of interest N/A
N f id hld N/A
am(if is e o regstere oersued securities)
Date of change N/A
No.whic and class of securities toh interest related prior to N/A
chanNote: Dto whic geetails are only required for a contract in relationh the interest has changed
Inter est acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

For and on behalf of Pro Medicus Limited

==> picture [125 x 59] intentionally omitted <==

Clayton Hatch Company Secretary 11 September 2013

  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002